StocksFundsScreenerSectorsWatchlists
AXNX

AXNX - Axonics Modulation Technologies Inc Stock Price, Fair Value and News

67.30USD-0.03 (-0.04%)Market Closed

Market Summary

AXNX
USD67.30-0.03
Market Closed
-0.04%

AXNX Stock Price

View Fullscreen

AXNX RSI Chart

AXNX Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

-565.58

Price/Sales (Trailing)

9.37

EV/EBITDA

872.96

Price/Free Cashflow

-616.7

AXNX Price/Sales (Trailing)

AXNX Profitability

EBT Margin

-2.39%

Return on Equity

-0.95%

Return on Assets

-0.84%

Free Cashflow Yield

-0.16%

AXNX Fundamentals

AXNX Revenue

Revenue (TTM)

366.4M

Rev. Growth (Yr)

27.72%

Rev. Growth (Qtr)

17.87%

AXNX Earnings

Earnings (TTM)

-6.1M

Earnings Growth (Yr)

891.43%

Earnings Growth (Qtr)

67.85%

Breaking Down AXNX Revenue

Last 7 days

-0.7%

Last 30 days

-0.7%

Last 90 days

-1.5%

Trailing 12 Months

15.4%

How does AXNX drawdown profile look like?

AXNX Financial Health

Current Ratio

10.73

Debt/Equity

1e-4

Debt/Cashflow

-22.65

AXNX Investor Care

Shares Dilution (1Y)

2.08%

Diluted EPS (TTM)

-0.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023295.9M319.8M342.6M366.4M
2022194.3M217.4M240.9M273.7M
2021119.6M150.3M161.9M180.3M
202039.0M52.8M86.7M111.5M
20192.0M3.3M4.4M13.8M
20180369.7K538.3K707.0K
2017000201.0K
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Axonics Modulation Technologies Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 31, 2024
keese kari leigh
sold
-236,331
67.7359
-3,489
chief financial officer
Jan 31, 2024
woock john
sold
-1,076,930
67.7359
-15,899
evp, chief mktg/strtgy officer
Jan 31, 2024
cohen raymond w
sold
-2,381,660
67.7359
-35,161
chief executive officer
Jan 31, 2024
ford alfred j jr
acquired
-
-
25,500
chief commercial officer
Jan 31, 2024
noblett karen
sold
-764,603
67.7359
-11,288
chief medical officer
Jan 31, 2024
sama rinda
acquired
-
-
28,000
chief operating officer
Jan 31, 2024
keese kari leigh
acquired
-
-
6,167
chief financial officer
Jan 31, 2024
noblett karen
acquired
-
-
27,500
chief medical officer
Jan 31, 2024
woock john
acquired
-
-
28,000
evp, chief mktg/strtgy officer
Jan 31, 2024
ford alfred j jr
sold
-1,125,430
67.7359
-16,615
chief commercial officer

1–10 of 50

Which funds bought or sold AXNX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
Legato Capital Management LLC
sold off
-100
-628,834
-
-%
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
reduced
-22.59
-5,948
35,933
-%
Apr 12, 2024
INSPIRION WEALTH ADVISORS, LLC
new
-
206,910
206,910
0.03%
Apr 12, 2024
HARBOR INVESTMENT ADVISORY, LLC
new
-
1,104
1,104
-%
Apr 11, 2024
FORT PITT CAPITAL GROUP, LLC
new
-
344,850
344,850
0.01%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
unchanged
-
88.00
897
-%
Apr 05, 2024
NBC SECURITIES, INC.
reduced
-0.15
5,000
46,000
-%
Apr 05, 2024
GAMMA Investing LLC
added
75.00
633
1,448
-%
Apr 05, 2024
CWM, LLC
reduced
-0.5
1,000
14,000
-%
Apr 05, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC
new
-
285,467
285,467
-%

1–10 of 44

Are Funds Buying or Selling AXNX?

Are funds buying AXNX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AXNX
No. of Funds

Unveiling Axonics Modulation Technologies Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
10.38%
5,260,830
SC 13G/A
Feb 12, 2024
fmr llc
-
0
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 25, 2024
blackrock inc.
8.3%
4,189,817
SC 13G/A
Dec 11, 2023
fmr llc
-
0
SC 13G/A
Mar 10, 2023
vanguard group inc
10.28%
5,092,888
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
9.82%
4,863,283
SC 13G/A
Jan 31, 2023
blackrock inc.
7.3%
3,630,843
SC 13G/A
Jun 06, 2022
cooperatieve gilde healthcare iv u.a.
0%
0
SC 13G/A

Recent SEC filings of Axonics Modulation Technologies Inc

View All Filings
Date Filed Form Type Document
Apr 04, 2024
8-K
Current Report
Mar 25, 2024
8-K
Current Report
Mar 07, 2024
DEFA14A
DEFA14A
Feb 29, 2024
10-K
Annual Report
Feb 28, 2024
8-K
Current Report
Feb 22, 2024
DEFM14A
DEFM14A
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report
Feb 07, 2024
PREM14A
PREM14A

Peers (Alternatives to Axonics Modulation Technologies Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
189.6B
40.1B
-5.40% 4.53%
33.12
4.73
-8.12% -17.45%
66.7B
19.5B
-2.42% -9.87%
53.13
3.42
4.02% -22.04%
22.9B
3.9B
-2.94% -12.25%
51.49
5.93
3.42% 23.09%
20.1B
14.8B
-4.93% -7.94%
7.56
1.36
2.12% 209.17%
MID-CAP
9.2B
12.3B
-4.49% -14.03%
22
0.74
-2.44% -22.68%
9.2B
3.5B
-1.69% 15.70%
32.17
2.62
4.97% 18.89%
8.5B
2.7B
-12.27% -39.23%
-13.41
3.2
-4.68% 82.43%
6.4B
4.0B
-6.21% -24.72%
-47.49
1.61
1.10% 85.84%
3.4B
366.4M
-0.75% 15.36%
-565.58
9.37
33.86% 89.83%
2.3B
6.6B
-5.91% -4.69%
11.86
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-6.61% -18.37%
-1.88
0.4
7.73% -1066.14%
380.0M
166.7M
0.59% -11.05%
-4.6
2.28
6.67% -456.34%
260.4M
324.0M
21.04% -28.41%
-1.35
0.8
-3.19% -337.41%
48.2M
52.3M
-22.35% -53.67%
-2.57
0.92
17.61% 19.28%
3.8M
3.7M
-16.76% 269.23%
-0.31
1.01
5.77% 8.23%

Axonics Modulation Technologies Inc News

Latest updates
Yahoo Finance Australia29 Mar 202407:00 am
The Motley Fool3 months ago

Axonics Modulation Technologies Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue17.9%109,735,00093,100,00092,894,00070,650,00085,918,00070,384,00068,980,00048,420,00053,135,00046,913,00045,869,00034,373,00034,783,00035,243,00015,213,00026,296,0009,946,0001,309,0001,488,0001,077,000494,000
Gross Profit19.8%82,760,00069,104,00070,190,00052,500,00062,967,00051,260,00050,196,00033,242,00035,391,00031,194,00028,734,00020,399,00022,131,00021,809,0006,750,00016,401,0005,408,000677,000716,000529,000249,000
Operating Expenses17.1%81,694,00069,791,00082,260,00066,866,00066,576,00067,635,00071,625,00056,775,00053,071,00047,696,00044,744,00042,015,00033,012,00030,578,00026,155,00031,106,00028,071,00025,724,00019,986,00014,148,0009,700,000
  S&GA Expenses15.9%55,094,00047,544,00044,270,00042,654,00043,824,00039,751,00039,381,00033,063,00031,338,00028,112,00025,411,00020,928,00018,284,00017,057,00014,220,00016,569,00016,301,00015,707,00010,750,0005,914,0001,416,000
  R&D Expenses18.9%9,714,0008,167,0008,949,0008,056,0008,103,0007,936,0007,135,00011,236,00010,182,0008,648,0009,098,0009,369,0008,111,0007,719,0006,370,0006,855,0006,118,0004,855,0004,874,0004,219,0004,783,000
EBITDA Margin295.1%0.01-0.01-0.07-0.13-0.18-0.28-0.32-0.34-0.38-0.39-0.39-0.50---------
Interest Expenses-12.5%14,00016,00039,000----1,000-1,0002,007,000170,000253,000256,000264,000329,000339,000367,000370,000360,000358,000
Income Taxes-161.8%-1,118,000-427,000-304,000-807,000-522,000-520,000-465,000-1,111,000-2,487,000528,0003,296,000-555,000---1,000--1,000--
Earnings Before Taxes55.8%5,456,0003,501,000-7,646,000-10,055,000143,000-16,772,000-21,908,000-23,779,000-17,653,000-16,722,000-21,852,000-23,058,000-11,348,000-9,168,000-19,783,000-14,615,000-22,751,000-25,006,000-19,060,000-13,117,000-9,665,000
EBT Margin41.8%-0.02-0.04-0.11-0.16-0.23-0.33-0.37-0.41-0.44-0.45-0.44-0.53---------
Net Income67.8%6,593,0003,928,000-7,342,000-9,248,000665,000-16,252,000-21,443,000-22,668,000-15,166,500-17,250,000-25,148,000-22,503,000-11,348,000-9,168,000-19,783,000-14,616,000-22,751,000-25,006,000-19,061,000-13,117,000-9,665,000
Net Income Margin52.7%-0.02-0.04-0.10-0.16-0.22-0.31-0.35-0.41-0.44-0.47-0.45-0.53---------
Free Cashflow-61.2%4,323,00011,151,000-19,465,000-1,575,0009,018,0002,884,000-1,476,000-9,458,000-7,860,000-3,678,000-12,323,000-25,706,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets9.0%720661649666659632514526548561566445342348349217220126146159172
  Current Assets3.4%491475455470465449313307321330332228328334336204212118138153165
    Cash Equivalents-28.9%10514714524023924120321322122923113124126928816017176.0083.0089.0098.00
  Inventory6.7%80.0075.0070.0066.0056.0058.0058.0062.0065.0070.0070.0071.0063.0044.0030.0019.0016.0013.008.005.004.00
  Net PPE-100.0%-7.006.007.007.007.007.007.007.006.006.006.006.006.006.005.003.003.003.003.003.00
  Goodwill4.3%99.0095.0099.0097.0094.0087.0095.0010310611010787.00---------
Liabilities64.3%82.0050.0048.0089.0089.0083.0076.0062.0066.0071.0061.0011555.0054.0051.0045.0037.0034.0032.0028.0029.00
  Current Liabilities28.7%46.0036.0032.0066.0065.0061.0030.0026.0027.0028.0024.0024.0046.0039.0031.0020.0012.0016.0011.007.006.00
  Long Term Debt-----------0.0075.00-6.0011.0016.0020.0014.0016.0018.0019.00
    LT Debt, Current----------0.000.000.0021.0015.0010.005.00-6.004.002.00-
    LT Debt, Non Current-----------0.0075.00-6.0011.0016.0020.0014.0016.0018.0019.00
Shareholder's Equity4.4%63861160157757055043846348249050433028729429817218392.00114131143
  Retained Earnings1.7%-380-386-390-383-374-374-358-337-314-299-282-257-234-223-213-194-179-156-131-112-99.65
  Additional Paid-In Capital1.1%1,0341,0221,010982970961821812804796788590522518513367363250247245243
Shares Outstanding0.2%51.0051.0050.0050.0050.0046.0045.0045.0043.0045.0041.0040.00---------
Float---2,500---2,647---2,893---1,136---633--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-54.4%5,63012,344-19,209-7819,3533,847-842-9,167-6,776-2,994-11,953-25,583-28,314-19,146-12,975-23,307-28,136-23,904-18,359-13,055-9,296
  Share Based Compensation-2.8%11,14811,47011,20410,7148,7578,2187,9057,1386,8446,6906,3275,3033,5823,7753,8163,9222,9212,7821,8751,142247
Cashflow From Investing-243.1%-37,922-11,053-68,623694-10,030-99,401-10,632-291-1,084-684-370-140,864-1,023-648-55311,87812,34217,45611,4404,049-48,115
Cashflow From Financing-34.2%578878-6,7661,930161131,8834801,4442021,523112,57356,2151,0551,296141,495344110,49211130844.00135,579

AXNX Income Statement

2023-12-31
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Comprehensive Income [Abstract]   
Net revenue$ 366,379$ 273,702$ 180,290
Cost of goods sold91,82576,03764,572
Gross profit274,554197,665115,718
Operating expenses   
Research and development34,88634,41037,297
General and administrative45,75440,23830,041
Sales and marketing189,562156,019105,789
Amortization of intangible assets9,0649,3837,241
Acquisition-related costs5,89822,5617,158
Acquired in-process research & development15,44700
Total operating expenses300,611262,611187,526
Loss from operations(26,057)(64,946)(71,808)
Other income (expense)   
Interest and other income16,6905,13340
Loss on disposal of property and equipment(1)(69)(91)
Interest and other income (expense)624(2,434)(7,426)
Other income (expense), net17,3132,630(7,477)
Loss before income tax (benefit) expense(8,744)(62,316)(79,285)
Income tax (benefit) expense(2,656)(2,618)782
Net loss(6,088)(59,698)(80,067)
Foreign currency translation adjustment9,280(18,587)(6,129)
Comprehensive income (loss)$ 3,192$ (78,285)$ (86,196)
Net loss per share, basic (in USD per share)$ (0.12)$ (1.28)$ (1.86)
Net loss per share, diluted (in USD per share)$ (0.12)$ (1.28)$ (1.86)
Weighted-average shares used to compute basic net loss per share (in shares)49,081,47046,684,47843,072,298
Weighted-average shares used to compute diluted net loss per share (in shares)49,081,47046,684,47843,072,298

AXNX Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 104,811$ 238,846
Short-term investments240,149118,365
Accounts receivable, net of allowance for credit losses of $442 and $321 at December 31, 2023 and 2022, respectively57,24344,817
Inventory, net79,94055,765
Prepaid expenses and other current assets9,2797,282
Total current assets491,422465,075
Restricted cash12,7140
Property and equipment, net10,7606,798
Intangible assets, net81,37586,253
Other assets24,2356,813
Goodwill99,41794,414
Total assets719,923659,353
Current liabilities  
Accounts payable18,4529,070
Accrued liabilities10,5276,520
Accrued compensation and benefits15,06015,495
Operating lease liabilities, current portion1,7771,562
Other current liabilities032,600
Total current liabilities45,81665,247
Operating lease liabilities, net of current portion25,8407,555
Deferred tax liabilities, net10,70316,412
Total liabilities82,35989,214
Commitments and contingencies (Note 4)
Stockholders’ equity  
Preferred stock, par value $0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2023 and 202200
Common stock, par value $0.0001 per share, 75,000,000 shares authorized at December 31, 2023 and 2022; 50,770,520 and 49,546,727 shares issued and outstanding at December 31, 2023 and 2022, respectively55
Additional paid-in capital1,033,778969,545
Accumulated deficit(380,352)(374,264)
Accumulated other comprehensive loss(15,867)(25,147)
Total stockholders’ equity637,564570,139
Total liabilities and stockholders’ equity$ 719,923$ 659,353
AXNX
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
 CEO
 WEBSITEaxonics.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES610

Axonics Modulation Technologies Inc Frequently Asked Questions


What is the ticker symbol for Axonics Modulation Technologies Inc? What does AXNX stand for in stocks?

AXNX is the stock ticker symbol of Axonics Modulation Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Axonics Modulation Technologies Inc (AXNX)?

As of Tue Apr 16 2024, market cap of Axonics Modulation Technologies Inc is 3.43 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AXNX stock?

You can check AXNX's fair value in chart for subscribers.

What is the fair value of AXNX stock?

You can check AXNX's fair value in chart for subscribers. The fair value of Axonics Modulation Technologies Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Axonics Modulation Technologies Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AXNX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Axonics Modulation Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether AXNX is over valued or under valued. Whether Axonics Modulation Technologies Inc is cheap or expensive depends on the assumptions which impact Axonics Modulation Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AXNX.

What is Axonics Modulation Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, AXNX's PE ratio (Price to Earnings) is -565.58 and Price to Sales (PS) ratio is 9.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AXNX PE ratio will change depending on the future growth rate expectations of investors.